Katerina L. Byanova - Concepedia

Author

Katerina L. Byanova

Also Known As

K. Byanova, K.L. Byanova, KATERINA L BYANOVA, Katerina Byanova, Katerina L Byanova, Katerina L. Byanova

Publications

382

Citations

H-Index

Concepts

All Affiliations

Katerina L. Byanova is an author at University of Geneva specializing in medicine, cytoskeleton, and extracellular matrix.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	151
2	Cell Biology	1	1	48
3	Cellular Physiology	1	1	48
4	Pathology	1	1	48
5	Surgical Oncology	1	1	103

Katerina L. Byanova

Publications

299

Citations

H-Index

Page 1

	Year	Citations
Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled trial Timothy B. Gardner, Chad Spangler, Katerina L. Byanova, Gastrointestinal Endoscopy Surgical OncologyOncologyPancreatic CancerNeoadjuvant TherapyGastrointestinal Oncology	2016	103
Rare, Nonsynonymous Variant in the Smooth Muscle-Specific Isoform of Myosin Heavy Chain, <i>MYH11</i> , R247C, Alters Force Generation in the Aorta and Phenotype of Smooth Muscle Cells Shao-Qing Kuang, Callie Kwartler, Katerina L. Byanova, Circulation Research	2012	92
Loss of Smooth Muscle α-Actin Leads to NF-κB–Dependent Increased Sensitivity to Angiotensin II in Smooth Muscle Cells and Aortic Enlargement Jiyuan Chen, Andrew M. Peters, Christina L. Papke, Circulation Research	2017	56
Smooth muscle hyperplasia due to loss of smooth muscle α-actin is driven by activation of focal adhesion kinase, altered p53 localization and increased levels of platelet-derived growth factor receptor-β Christina L. Papke, Jiumei Cao, Callie Kwartler, Human Molecular Genetics Vascular DiseaseMuscle FunctionPathologyCytoskeletonCell Growth	2013	48

Page 1